Objectives: We intended to find out if Laser treatments, ablative and non-ablative as monotherapy or in combination can represent a meaningful treatment options in selected cases.
Introduction: With a clear increase in the incidence and a continuously earlier onset, the
treatment options for localized resectionable basal cell carcinoma
include micrographically controlled surgery, simple excision, curettage, laser ablation,
cryosurgery, imiquimod, 5-fluorouracil, photodynamic treatment and radiotherapy.
Nonsurgical treatment options are more suited for cases in which surgical procedures lead to disfigurement or functional impairments or for patients with a high surgical risk. Laser treatment, ablative and non-ablative as monotherapy or in combination can represent a meaningful tre
Materials / method: IN pub med and and multiple journals we searched for the use of lasers in NMSC , esp. BCC, their paramenters and results.
Results: Laser ablation with Er:YAG and CO2 lasers continues to be of interest as a potentially less invasive alternative to surgery for the treatment of low-risk superficial and nodular subtypes of BCCs. The lack of histopathological confirmation has been a limitation but a reflectance confocal microscopy (RCM) imaging-guided approach offers cellular-level histopathology-like feedback directly on the patient.
Ablative fractional lasers (AFXL) enhance uptake of topical therapeutics and the concept of fractional laser-assisted drug delivery has now been taken into clinical practice using 5 FU, Imiquimod
Conclusion: In recent years there has been an increase in evidence about the effects of laser treatment of basal cell carcinoma; nevertheless, further studies with a high level of evidence are necessary.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。